Mahesh Ravindra Kudrimoti MD

Radiation Oncology•Greendale, IN

Gastrointestinal Cancer, Gynecologic Cancer, Head & Neck, Sarcoma

Professor, Program Director, Vice-Chair Clinical Operations Radiation Medicine, University of Kentucky College of Medicine

Join to View Full Profile

17525 Greendale Plaza DrGreendale, IN 47025
Phone+1 859-301-2238
Fax+1 859-301-4946

Education & Training

University of Kentucky College of MedicineResidency, Radiation Oncology, 1997 - 2001
Robert Packer HospitalInternship, Transitional Year, 1996 - 1997
Osmania Medical College NTR UHSClass of 1991

Certifications & Licensure

KY State Medical License 2000 - 2026
IN State Medical License 2023 - 2025
WV State Medical License 2023 - 2024
PA State Medical License 1996 - 1997
American Board of Radiology Radiation Oncology

Awards, Honors, & Recognition

America's Top Doctors Castle Connolly, 2014-2020
America's Top Doctors for Cancer Castle Connolly, 2013-2020
Top reviewer Int Journal radiation Oncology Biology, 2018
Top Reviewer Brachytherapy Journal, 2018
Best doctors Best doctors, 2009-2016
Abraham Flexner Master Educator Teaching Award Univ of Kentucky, 2011
ARRO Educator Award ASTRO, 2006-2011
Join now to see all

Clinical Trials

RT With or Without Cetuximab in Treating Patients Who Have Undergone Surgery for Locally Advanced Head and Neck Cancer Start of enrollment: 2010 Mar 31
Active, not recruiting
Phase 3
Gemcitabine Hydrochloride With or Without Erlotinib Hydrochloride Followed by the Same Chemotherapy Regimen With or Without Radiation Therapy and Capecitabine or Fluorouracil in Treating Patients With Pancreatic Cancer That Has Been Removed by Surgery Start of enrollment: 2010 Apr 05
ACTIVE_NOT_RECRUITING
PHASE3
Nicotine Levels With Response Rates to Radiation Alone or With Chemo In Head & Neck Cancer Start of enrollment: 2007 Aug 01
Completed
Testing Docetaxel-Cetuximab or the Addition of an Immunotherapy Drug, Atezolizumab, to the Usual Chemotherapy and Radiation Therapy in High-Risk Head and Neck Cancer Start of enrollment: 2013 Mar 22
RECRUITING
PHASE2, PHASE3
A Dose Escalating Study of SGX942 for Oral Mucositis in Patients With Head and Neck Cancer Start of enrollment: 2013 Dec 01
Completed
Phase 2
EC-18 for Oral Mucositis in Patients With Concomitant Chemoirradiation Start of enrollment: 2018 Jul 03
Completed
Phase 2
De-intensified Radiation Therapy With Chemotherapy (Cisplatin) or Immunotherapy (Nivolumab) in Treating Patients With Early-Stage, HPV-Positive, Non-Smoking Associated Oropharyngeal Cancer Start of enrollment: 2019 Oct 09
ACTIVE_NOT_RECRUITING
PHASE2, PHASE3
Join now to see all

Publications & Presentations

PubMed

Head and Neck Cancers.
Archana Kudrimoti, Mahesh R Kudrimoti
Primary Care. 2025-03-01
Association between Locoregional Failure and NFE2L2/KEAP1/CUL3 Mutations in NRG/RTOG 9512: A Randomized Trial of Radiation Fractionation in T2N0 Glottic Cancer.
Li Guan, Pedro A Torres-Saavedra, Xiaobei Zhao, Michael B Major, Brittany J Holmes
Clinical Cancer Research. 2024-12-10
Effects of Interfraction Dose Variations of Target and Organs at Risk on Clinical Outcomes in High Dose Rate Brachytherapy for Cervical Cancer.
Brien Washington, Dennis Cheek, Denise Fabian, Mahesh Kudrimoti, Damodar Pokhrel
Cancers. 2023-10-05

Journal Articles

Diffuse Optical Measurements of Head and Neck Tumor Hemodynamics for Early Prediction of Chemoradiation Therapy Outcomes
Sameera Kumar, Scott D Stevens, Mahesh Kudrimoti, SPIE

Press Mentions

UK Doctoral Candidate Tackling Black Health DisparitiesMay 19th, 2021
'Patients Always Remembered Seeing John': How Dr. DeMasi's Memory Lives on at UKDecember 17th, 2021

Professional Memberships

American Society of Clinical Oncology - ASCO
Member